Toxicity of stainless and mild steel particles generated from gas-metal arc welding in primary human small airway epithelial cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 11 2021
Historique:
received: 30 06 2021
accepted: 21 10 2021
entrez: 9 11 2021
pubmed: 10 11 2021
medline: 27 1 2022
Statut: epublish

Résumé

Welding fumes induce lung toxicity and are carcinogenic to humans but the molecular mechanisms have yet to be clarified. The aim of this study was to evaluate the toxicity of stainless and mild steel particles generated via gas-metal arc welding using primary human small airway epithelial cells (hSAEC) and ToxTracker reporter murine stem cells, which track activation of six cancer-related pathways. Metal content (Fe, Mn, Ni, Cr) of the particles was relatively homogenous across particle size. The particles were not cytotoxic in reporter stem cells but stainless steel particles activated the Nrf2-dependent oxidative stress pathway. In hSAEC, both particle types induced time- and dose-dependent cytotoxicity, and stainless steel particles also increased generation of reactive oxygen species. The cellular metal content was higher for hSAEC compared to the reporter stem cells exposed to the same nominal dose. This was, in part, related to differences in particle agglomeration/sedimentation in the different cell media. Overall, our study showed differences in cytotoxicity and activation of cancer-related pathways between stainless and mild steel welding particles. Moreover, our data emphasizes the need for careful assessment of the cellular dose when comparing studies using different in vitro models.

Identifiants

pubmed: 34750422
doi: 10.1038/s41598-021-01177-7
pii: 10.1038/s41598-021-01177-7
pmc: PMC8575907
doi:

Substances chimiques

Air Pollutants, Occupational 0
Reactive Oxygen Species 0
Stainless Steel 12597-68-1
Steel 12597-69-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21846

Subventions

Organisme : AFA Försäkring
ID : 160226
Organisme : VR-RFI
ID : 2017-00646_9
Organisme : Stiftelsen för Strategisk Forskning
ID : RIF14-0053
Organisme : Forskningsrådet om Hälsa, Arbetsliv och Välfärd
ID : 2017-00690
Organisme : Forskningsrådet om Hälsa, Arbetsliv och Välfärd
ID : 2017-00252

Informations de copyright

© 2021. The Author(s).

Références

Scand J Work Environ Health. 2007 Oct;33(5):379-86
pubmed: 17973064
Environ Mol Mutagen. 2015 Oct;56(8):684-93
pubmed: 26013103
J Toxicol Environ Health A. 1999 Nov 26;58(6):343-63
pubmed: 10580758
Scand J Work Environ Health. 2021 Sep 27;:
pubmed: 34570895
Part Fibre Toxicol. 2018 Jul 17;15(1):32
pubmed: 30016969
Nanotoxicology. 2018 Aug;12(6):602-620
pubmed: 29790399
NanoImpact. 2017 Jan;5:61-69
pubmed: 30734006
Respir Res. 2019 Mar 4;20(1):49
pubmed: 30832670
Nanotoxicology. 2011 Dec;5(4):700-10
pubmed: 21281223
Nanomaterials (Basel). 2020 Jan 06;10(1):
pubmed: 31935871
Environ Sci Process Impacts. 2013 Jan;15(1):214-24
pubmed: 24592438
Lancet Oncol. 2017 May;18(5):581-582
pubmed: 28408286
Part Fibre Toxicol. 2010 Nov 03;7:32
pubmed: 21047424
Am J Epidemiol. 2012 Apr 1;175(7):706-14
pubmed: 22343633
Arch Toxicol. 2019 Feb;93(2):435-451
pubmed: 30456486
J Appl Physiol (1985). 2003 May;94(5):1719-25
pubmed: 12533493
Part Fibre Toxicol. 2014 Sep 17;11:49
pubmed: 25227272
Ann Occup Hyg. 2013 Jan;57(1):6-25
pubmed: 22997412
Occup Environ Med. 2016 Apr;73(4):254-61
pubmed: 26865654
Fundam Appl Toxicol. 1995 Nov;28(1):41-50
pubmed: 8566482
Part Fibre Toxicol. 2014 Feb 17;11:11
pubmed: 24529161
Part Fibre Toxicol. 2008 Sep 08;5:12
pubmed: 18778475
Arch Toxicol. 2017 Aug;91(8):2953-2962
pubmed: 28054104
PLoS One. 2014 Jun 30;9(6):e101310
pubmed: 24977413
Part Fibre Toxicol. 2014 Sep 02;11:41
pubmed: 25179117
Nanotoxicology. 2019 Dec;13(10):1293-1309
pubmed: 31418618
Nanotoxicology. 2016;10(2):140-50
pubmed: 25938281
Pharmacol Ther. 2021 Apr;220:107742
pubmed: 33176178
Toxicology. 2018 Nov 1;409:24-32
pubmed: 30055299
Nanotoxicology. 2017 Aug;11(6):725-736
pubmed: 28660804
Inhal Toxicol. 2011 Feb;23(2):112-20
pubmed: 21309664
Exp Lung Res. 1997 May-Jun;23(3):205-27
pubmed: 9184789
Toxicology. 2015 Feb 3;328:168-78
pubmed: 25549921
Occup Environ Med. 2019 Jun;76(6):422-431
pubmed: 30948521
Scand J Work Environ Health. 2008 Dec;34(6):444-50
pubmed: 19137206
Small. 2014 Jan 29;10(2):385-98
pubmed: 24039004

Auteurs

Andrea Cediel-Ulloa (A)

Institute of Environmental Medicine, Karolinska Institutet, Box 210, 171 77, Stockholm, Sweden.
Department of Organismal Biology, Uppsala University, Uppsala, Sweden.

Christina Isaxon (C)

Ergonomics and Aerosol Technology, Lund University, Lund, Sweden.
NanoLund, Lund University, Lund, Sweden.

Axel Eriksson (A)

Ergonomics and Aerosol Technology, Lund University, Lund, Sweden.
NanoLund, Lund University, Lund, Sweden.

Daniel Primetzhofer (D)

Department of Physics and Astronomy, Applied Nuclear Physics, Uppsala University, Uppsala, Sweden.
The Tandem Laboratory, Uppsala University, Uppsala, Sweden.

Mauricio A Sortica (MA)

The Tandem Laboratory, Uppsala University, Uppsala, Sweden.

Lars Haag (L)

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Remco Derr (R)

Toxys, Leiden, The Netherlands.

Giel Hendriks (G)

Toxys, Leiden, The Netherlands.

Jakob Löndahl (J)

Ergonomics and Aerosol Technology, Lund University, Lund, Sweden.
NanoLund, Lund University, Lund, Sweden.

Anders Gudmundsson (A)

Ergonomics and Aerosol Technology, Lund University, Lund, Sweden.
NanoLund, Lund University, Lund, Sweden.

Karin Broberg (K)

Institute of Environmental Medicine, Karolinska Institutet, Box 210, 171 77, Stockholm, Sweden.

Anda R Gliga (AR)

Institute of Environmental Medicine, Karolinska Institutet, Box 210, 171 77, Stockholm, Sweden. anda.gliga@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH